Friday Favorites: What Causes Cancer to Metastasize and How to Potentially Help Control it with Diet

Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.

A type of saturated fat concentrated in meat and dairy seems to cause cancer to metastasize, check out the video to find out more.

Metastasis formation is the leading cause of death in cancer patients. That’s how most people die of cancer. It’s not the primary tumor, but the cancer spreading through the body. “[It’s] estimated that metastasis is responsible for [90 percent] of cancer deaths”, with little progress made in stopping the spread despite our modern medical armamentarium. In fact, we can sometimes make it worse: Therapy-Induced Metastasis. All the typical cancer treatments, radiation, chemotherapy, surgery—even just poking the tumors with fine needle biopsies—have the potential to contribute to the problem. I mean, you can imagine how cutting around a tumor, severing the blood vessels, might lead to the migration of residual tumor cells. But why chemotherapy? How might chemo exacerbate metastases? Despite reducing the size of primary tumors, chemotherapy can change the surrounding tissues, resulting in an increased escape of cancer cells into the blood stream. Sometimes chemo/surgery/radiation are entirely justified, but sometimes these treatments can make things worse. If only we had a way to treat the cause of the cancer spreading.

The development of antimetastatic therapies has been hampered by the fact that we haven’t been able to identity the cells that initiate metastasis.  But then, this landmark study was published. Researchers found a subpopulation of human cancer cells “unique in their ability to initiate metastasis”, all expressing high levels of a fat receptor known as CD36, dubbed “the fat controller.” It turns out palmitic acid or a high-fat diet specifically boosts the metastatic potential of these cancer cells. Where do you find palmitic acid? Although originally discovered in palm oil, it’s most concentrated in meat and dairy. “Emerging evidence shows that palmitic acid . . . serves as a signaling molecule regulating the progression and development of many diseases at the molecular level”––and that’s the saturated fat that is recognized by the CD36 receptor on the cancer cells. And we know that’s to blame, because if you block the CD36 receptor, you block the metastases.

Now this was for a human cancer; however, it was a human cancer implanted into mice, but clinically (meaning in cancer patients), the presence of these CD36-studded metastasis-initiating cells does indeed correlate with a poor prognosis. For example, CD36 appears to drive the progression of brain tumors. If you look at the survival curves, those with tumors with less CD36 expression lived significantly longer. The same with breast cancer mortality. No surprise, since “CD36 [appears to play] a critical role in [the] proliferation, migration, and…growth of…breast cancer cells.” Inhibit CD36, and you can inhibit “the migration and invasion of the breast cancer cells.” Cancer cell migration and invasion before and after CD36 inhibition.

And not just in “human melanoma- and breast cancer-derived tumors.” Now we suspect that “…CD36…drives ovarian cancer progression and metastasis” too, since we can inhibit ovarian cancer cell invasion and migration and block both lymph node and blood-borne metastasis by blocking CD36. We see the same kind of effect with prostate cancer. Suppress the uptake of fat by prostate cancer cells, and you can suppress the tumor. This was all studied with receptor-blocking drugs and antibodies in a laboratory setting, though. If these metastasis-initiating cancer cells particularly rely on dietary fat to promote the spread of cancer, why not just block the dietary fat in the first place?

Cancer cells love fat and cholesterol. The reason why fat metabolism may fuel cancer’s spread is because there is so much energy stored in fat. “Hence, … metastatic cells might take advantage of this feature to obtain the high amount of energy that is likely to be required for them to anchor and [set up shop throughout the body].”

“The time when sugar was considered as the major, if not only, fuel to support cancer cell proliferation is over.” There appears to be “a fatter way to metastasize”. No wonder “…high-fat [diets may] …play a crucial role in increasing the risk of different cancer types, …[including] several advanced cancers.” Okay, if dietary fat may be “greasing the wheels of the cancer machine,” might there be specific dietary regimens we could use to starve cancers of dietary fat? You don’t know until you put it to the test, which we’ll cover next.

“Metastasis is the leading cause of cancer-[related death].” Cancer kills, because cancer spreads. For example, the five-year survival rate for women with localized breast cancer is nearly 99 percent, but that drops to just 27 percent in those with metastasized cancer. Yet “our ability to effectively treat metastatic disease has not changed significantly in the past few decades.” You know things are getting desperate when there are papers like this: “Targeting Metastasis with Snake Toxins.”

Now, we do have built-in defenses––natural killer cells that roam the body killing off budding tumors, and I have videos on boosting natural killer cell activity. But as I explained in the last video, there’s a fat receptor called CD36 that appears to be essential for cancer cells to spread, and these cancer cells respond to dietary fat intake. But not all fat.

CD36 is upregulated by palmitic acid, as much as a 50-fold increase within 12 hours. Palmitic acid is a saturated fat found in junk food made from palm oil, but it is most concentrated in meat and dairy. This may explain why, if you look at “dietary fat and breast cancer mortality,” there was no difference in risk of breast-cancer-specific death for women in the highest versus lowest category of total fat intake. But, you’re about 50 percent more likely to die of breast cancer if you eat a lot of saturated fat. The systematic review and “…meta-analyses [conclude]… that saturated fat intake negatively impacts upon breast cancer survival.”

This may explain why “intake of high-fat dairy, but not low-fat dairy, was related to a higher risk of mortality after breast cancer diagnosis.” If it was the dairy protein, like casein, that was a problem; the skim milk might be even worse. But no, it was the saturated butterfat, maybe because it triggered that CD36-induced cancer-spreading mechanism. “…Women who consumed one or more servings per day of high-fat dairy had … [about a 50] percent higher risk of dying from breast cancer.”

We see the same thing with “dairy intake in relation to prostate cancer survival.” “…Drinking high-fat milk [appeared to increase] the risk of dying from prostate cancer by as much as 600 percent in patients with localized prostate cancer,” but “low-fat milk was not associated with such an increase in risk.” So, it seemed to be the animal fat, rather than the animal protein, and this is consistent with what Harvard researchers found in the United States.

More evidence that the fat receptor CD36 is involved is “…that the risk of colorectal cancer for meat consumption increased from [just doubling risk to octupling risk]”—multiplying the odds of getting cancer eight-fold for those who carry a specific type of CD36 gene. So, “Is It Time to Give Breast Cancer Patients a Prescription for a Low-Fat Diet?” A cancer diagnosis is a “teachable moment” if there ever was one to motivate people to make changes to their lifestyle. But provision of  evidence-based guidelines is essential, and you don’t know, until you put it to the test.

 “A randomized, prospective, multicenter clinical trial to test the effect of a dietary intervention designed to reduce fat intake in women with resected, early-stage breast cancer…” (meaning the women had their breast cancer surgically removed and were praying it doesn’t come back). The dietary intervention group dropped their fat intake from about 30 percent of calories down to 20 percent of calories, dropping saturated fat intake about 40 percent, and maintained that 40-percent lower intake after one year, three years, five years. And… “after approximately five years of follow-up, [the] women in the dietary intervention group had a 24-percent lower risk of relapse…”, a 24-percent lower risk of the cancer coming back.

That was the WINS study, the Women’s Intervention Nutrition Study. Then there was the Women’s Health Initiative study, where again, women were randomized to drop their fat intake down to about 20 percent of calories, and again, those in the dietary intervention group experienced increased breast cancer survival, meaning “a dietary change may be able to influence breast cancer outcome[s].” And not only was breast cancer survival significantly greater; the women also experienced a reduction in heart disease and a reduction in diabetes as a little side bonus.

Please consider volunteering to help out on the site.

• Elia I, Doglioni G, Fendt S-M. Metabolic hallmarks of metastasis formation. Trends Cell Biol. 2018;28(8):673-84.
• Lee W-C, Kopetz S, Wistuba II, Zhang J. Metastasis of cancer: when and how? Ann Oncol. 2017;28(9):2045-7.
• Martin OA, Anderson RL. Editorial: Therapy-induced metastasis. Clin Exp Metastasis. 2018;35(4):219-21.
• Middleton JD, Stover DG, Hai T. Chemotherapy-exacerbated breast cancer metastasis: A paradox explainable by dysregulated adaptive-response. Int J Mol Sci. 2018;19(11):3333.
• Pascual G, Avgustinova A, Mejetta S, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41-5.
• Villanueva MT. Metastasis: The fat controller. Nat Rev Cancer. 2017;17(2):76-7.
• Carta G, Murru E, Banni S, Manca C. Palmitic acid: Physiological role, metabolism and nutritional implications. Front Physiol. 2017;8:902.
• Fatima S, Hu X, Gong RH, et al. Palmitic acid is an intracellular signaling molecule involved in disease development. Cell Mol Life Sci. 2019;76(13):2547-57.
• Hale JS, Otvos B, Sinyuk M, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014;32(7):1746-58.
• Liang Y, Han H, Liu L, et al. CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells. Oncogenesis. 2018;7:98.
• Zaoui M, Morel M, Ferrand N, et al. Breast-associated adipocytes secretome induce fatty acid uptake and invasiveness in breast cancer cells via CD36 independently of body mass index, menopausal status and mammary density. Cancers (Basel). 2019;11(12):2012.
• Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37(17):2285-301.
• Watt MJ, Clark AK, Selth LA, et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med. 2019;11(478):eaau5758.
• Li Z, Kang Y. Lipid metabolism fuels cancer's spread. Cell Metab. 2017;25(2):228-30.
• Corbet C, Feron O. Emerging roles of lipid metabolism in cancer progression. Curr Opin Clin Nutr Metab Care. 2017;20(4):254-60.
• Yeudall WA, Shahoumi L. A fatter way to metastasize. Oral Dis. 2018;24(5):679-81.
• Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer. Cell Metab. 2020;31(1):62-76.
• Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006;98(24):1767-76.
• Alečković M, McAllister SS, Polyak K. Metastasis as a systemic disease: Molecular insights and clinical implications. Biochim Biophys Acta Rev Cancer. 2019;1872(1):89-102.
• Decoding cancer metastasis. Nat Cell Biol. 2018;20(8):859.
• Urra FA, Araya-Maturana R. Targeting metastasis with snake toxins: Molecular mechanisms. Toxins (Basel). 2017;9(12):390.
• López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of metastasis by NK cells. Cancer Cell. 2017;32(2):135-54.
• Hua W, Huang HZ, Tan LT, et al. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress. PLoS One. 2015;10(5):e0127507.
• Brennan SF, Woodside JV, Lunny PM, Cardwell CR, Cantwell MM. Dietary fat and breast cancer mortality: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2017;57(10):1999-2008.
• Kroenke CH, Kwan ML, Sweeney C, Castillo A, Caan BJ. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013;105(9):616-23.
• Printz C. Link between high-fat dairy consumption and poor breast cancer survival. Cancer. 2013;119(14):2517.
• Downer MK, Batista JL, Mucci LA, et al. Dairy intake in relation to prostate cancer survival. Int J Cancer. 2017;140(9):2060-9.
• Kuriki K, Hamajima N, Chiba H, et al. Increased risk of colorectal cancer due to interactions between meat consumption and the CD36 gene A52C polymorphism among Japanese. Nutr Cancer. 2005;51(2):170-77.
• Ligibel JA. Is it time to give breast cancer patients a prescription for a low-fat diet? JNCI Cancer Spectr. 2018;2(4):pky066.
• Chlebowski RT, Aragaki AK, Anderson GL, et al. Association of low-fat dietary pattern with breast cancer overall survival: A secondary analysis of the Women's Health Initiative Randomized Clinical Trial. JAMA Oncol. 2018;4(10):e181212.
• Prentice RL, Aragaki AK, Howard BV, et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. J Nutr. 2019;149(9):1565-74.

Video production by Glass Entertainment

Motion graphics by Avo Media